Literature DB >> 31097156

Reasons for Lack of Improvement in Treatment With Evidence-Based Therapies in Heart Failure.

Biykem Bozkurt1.   

Abstract

Entities:  

Keywords:  dose; guideline-directed therapy; guidelines; heart failure; maximum tolerated dose; target dose; treatment; treatment gap

Year:  2019        PMID： 31097156     DOI： 10.1016/j.jacc.2019.03.464

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

Review 1.  Potential association with malnutrition and allocation of combination medical therapies in hospitalized heart failure patients with reduced ejection fraction.

Authors:  Yumiko Kawakubo; Yasuyuki Shiraishi; Shun Kohsaka; Takashi Kohno; Ayumi Goda; Yuji Nagatomo; Yosuke Nishihata; Mike Saji; Makoto Takei; Yukinori Ikegami; Nozomi Niimi; Alexander Tarlochan Singh Sandhu; Shintaro Nakano; Tsutomu Yoshikawa; Keiichi Fukuda
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

2.  Relation of Household Income to Access and Adherence to Combination Sacubitril/Valsartan in Heart Failure: A Retrospective Analysis of Commercially Insured Patients.

Authors:  Amber E Johnson; Gretchen M Swabe; Daniel Addison; Utibe R Essien; Khadijah Breathett; LaPrincess C Brewer; Sula Mazimba; Selma F Mohammed; Jared W Magnani
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2022-05-13

Review 3.  Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction.

Authors:  Stephen J Greene; Xi Tan; Yu-Chen Yeh; Mark Bernauer; Omer Zaidi; Mei Yang; Javed Butler
Journal:  Heart Fail Rev       Date:  2021-01-20       Impact factor: 4.214

4.  Modifications of medical treatment and outcome after percutaneous correction of secondary mitral regurgitation.

Authors:  Davide Stolfo; Matteo Castrichini; Elena Biagini; Miriam Compagnone; Antonio De Luca; Thomas Caiffa; Alessandra Berardini; Giancarlo Vitrella; Renata Korcova; Andrea Perkan; Marco Foroni; Marco Merlo; Giulia Barbati; Francesco Saia; Claudio Rapezzi; Gianfranco Sinagra
Journal:  ESC Heart Fail       Date:  2020-05-19

5.  Optimizing sodium-glucose co-transporter 2 inhibitor use in patients with heart failure with reduced ejection fraction: A collaborative clinical practice statement.

Authors:  Bruce A Warden; Johannes Steiner; Albert Camacho; Khoa Nguyen; Jonathan Q Purnell; P Barton Duell; Courtney Craigan; Diane Osborn; Sergio Fazio
Journal:  Am J Prev Cardiol       Date:  2021-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.